Lipedema

Populations and Risk Factors

• Almost exclusively affects females (male cases are exceptionally rare and typically associated with liver disease, hypogonadism, or growth hormone deficiency)
• Strong hereditary component — family history of similar body morphology in female relatives is present in approximately 60% of cases
• Hormonal triggers: onset correlates with puberty, pregnancy, menopause, oral contraceptive use, and gynecological surgery — all periods of estrogen fluctuation
• Obesity is a common comorbidity (approximately 50% of lipedema patients are also obese), but lipedema fat is distinct from obesity fat and does not respond to caloric restriction
• Prevalence approximately 7–11% of adult women; severely underdiagnosed
• Hypermobility (Ehlers-Danlos spectrum) may co-occur — some studies suggest higher joint hypermobility prevalence in lipedema patients

Causes and Pathophysiology

Adipocyte Pathology

• Lipedema involves hypertrophy (enlargement) and hyperplasia (increased number) of adipocytes in the subcutaneous layer, particularly in the thighs, buttocks, lower legs, and sometimes upper arms
• The pathological fat is hormonally responsive but metabolically resistant — it does not mobilize with caloric deficit, distinguishing it from dietary obesity
• Adipocytes become fragile and prone to rupture, releasing inflammatory mediators into the interstitial space, which explains the characteristic pain sensitivity and easy bruising
• Microangiopathy (small vessel fragility) contributes to capillary permeability, interstitial edema, and the characteristic bruising that occurs with minimal or no trauma

Tissue Nodularity and Fibrosis

• Stage I: small, soft nodules palpable within otherwise normal-feeling subcutaneous tissue — "rice grain" or "pea-sized" nodularity
• Stage II: larger nodules (walnut-sized) embedded in increasingly firm, irregular tissue; surface becomes visibly uneven
• Stage III: large, deforming fat masses (lobules) particularly at the medial thighs and knees; tissue is firm and fibrotic; significant functional impairment
• Stage IV (lipo-lymphedema): fat mass obstructs lymphatic drainage, producing secondary lymphedema superimposed on the lipedema fat — the tissue now has both fat nodularity and lymphatic fluid retention; Stemmer sign may become positive at this stage
• Fibrosis develops progressively as chronic interstitial inflammation stimulates fibroblast activity — in later stages, tissue texture shifts from soft and nodular to firm and indurated, which changes how the tissue responds to manual therapy

Biomechanical and Secondary MSK Consequences

• Bilateral limb heaviness increases load on hips, knees, and ankles — accelerates degenerative changes particularly in the medial knee compartment
• Altered gait pattern: wider base, lateral trunk sway, reduced stride length — compensatory patterns develop in hip abductors, lumbar spine, and pelvic floor
• Medial thigh fat lobules can cause mechanical chafing, skin breakdown, and altered knee alignment (functional valgus)
• Pain with pressure and movement leads to avoidance behavior and progressive deconditioning
• Psychosocial burden is significant — misdiagnosis as "obesity" and failed diet/exercise attempts create frustration, depression, and avoidance of healthcare

Signs and Symptoms

By Stage

General Presentation

• Bilateral symmetrical limb enlargement — always symmetrical; asymmetrical presentation should prompt investigation for other causes
• Sparing of hands and feet — the classic "bracelet" or "cuff" sign at wrists/ankles where pathological fat stops abruptly
• Pain on pressure (adiposalgia) — characteristic and distinguishes from simple obesity where fat is generally non-tender
• Easy bruising with minimal or no trauma — due to capillary fragility and microangiopathy
• Heaviness and fatigue in the affected limbs, especially with prolonged standing
• Negative Stemmer sign in Stages I–III (distinguishes from lymphedema where Stemmer is positive)
• Fat distribution does not change with weight loss — the lipedema areas remain disproportionately enlarged even with significant caloric restriction

Assessment Profile

Subjective Presentation

• Chief complaint: "My legs are heavy and painful," "I bruise if you just touch me," "No matter how much I diet, my legs stay the same size," or "My legs have always been disproportionate to the rest of my body" — disproportionate limb size, pain on pressure, and resistance to weight loss are the dominant concerns
• Pain quality: diffuse, deep aching in the affected limbs; tenderness on pressure that is disproportionate to the force applied; spontaneous pain in advanced stages; pain worsens with prolonged standing, heat, and toward the end of the day
• Onset: typically begins or worsens at hormonally significant transitions — puberty, pregnancy, menopause, oral contraceptive initiation, or gynecological surgery; slow progressive course over years; family history of similar limb morphology in female relatives
• Aggravating factors: prolonged standing or sitting; heat and humidity; end of the day (gravitational fluid accumulation); moderate pressure to affected tissue; high-impact exercise (increases pain and bruising)
• Easing factors: elevation of the affected limbs; cool temperatures; compression garments (medical-grade); aquatic exercise (hydrostatic pressure provides natural compression); gentle movement
• Red flags: rapid unilateral limb swelling — rule out DVT; Stemmer sign becoming positive — indicates transition to lipo-lymphedema requiring CDT referral; skin breakdown in tissue folds — infection risk; significant functional decline — may indicate progression requiring medical reassessment

Observation

• Local inspection: bilateral symmetrical limb enlargement with visible disproportion between limbs and trunk; skin surface may appear normal (Stage I) or increasingly dimpled, uneven, and lobular (Stages II–IV); bruising in various stages of healing often present without reported trauma; "bracelet" or "cuff" effect at wrists/ankles where fat deposition abruptly stops; skin folds at the medial knee or thigh in advanced stages
• Posture: compensatory lumbar hyperlordosis or lateral trunk shift from lower limb heaviness; pelvic anterior tilt from hip flexor overload; bilateral genu valgum from medial compartment loading
• Gait: widened base of support; lateral trunk sway; shortened stride length; reduced hip extension from deconditioning and limb heaviness; possible Trendelenburg-like pattern from hip abductor fatigue under chronic increased load

Palpation

• Tone: generalized muscle deconditioning in the affected limbs rather than specific hypertonicity; compensatory hypertonicity in lumbar erectors, quadratus lumborum, and hip abductors (gluteus medius) from altered gait mechanics; hip flexors may be shortened from prolonged sitting avoidance of activity
• Tenderness: diffuse tenderness in the subcutaneous tissue of the affected limbs — characteristic and diagnostic; pain on palpation is disproportionate to the pressure applied (adiposalgia); medial knee and medial thigh are particularly sensitive in later stages; tenderness is bilateral and symmetrical
• Temperature: typically normal; mild warmth may be present in areas of active interstitial inflammation; cool extremities may indicate concurrent venous insufficiency (common comorbidity)
• Tissue quality: the primary diagnostic domain — palpate for nodularity progressing from fine "rice grain" (Stage I) to walnut-sized (Stage II) to large lobular masses (Stage III); tissue texture ranges from soft-nodular (early) to firm-fibrotic (late); negative pitting on edema test in Stages I–III (fat does not pit like fluid); Stemmer sign negative (skin at the base of the second toe can be pinched and lifted, unlike in lymphedema); circumference measurement comparison between limbs and over time is valuable for tracking progression

Motion Assessment

• AROM: joint ROM is typically preserved in early stages; in advanced stages (III–IV), large fat masses may mechanically restrict knee flexion (medial thigh lobules), hip abduction, and hip flexion; trunk rotation may be limited by abdominal and flank lipedema fat
• PROM / end-feel: soft tissue approximation end-feel from fat mass rather than capsular or bony restriction — the fat itself is the mechanical block; this is distinctly different from joint pathology
• Resisted testing: strength may be reduced from deconditioning and pain avoidance; proximal muscles (hip abductors, extensors) are typically weaker from chronic underuse; no primary muscle pathology

Special Test Cluster

Staging note: Stage is determined primarily by tissue texture and morphology on palpation (nodularity, fibrosis, lobules), not by limb size alone. A client with smaller limbs but advanced fibrosis may be Stage III.

Differential Assessment